Bristol’s Growth Plans Take A Hit As Cobenfy Fails As A Schizophrenia Add-On

Setback Follows Camzyos Stumble In nHCM

 
• By Mandy Jackson
  
Prescribers already treat schizophrenia with combination therapy without approved adjunctive medicines (Shutterstock)

More from Clinical Trials

More from Scrip